000 01906 a2200529 4500
005 20250517042408.0
264 0 _c20160209
008 201602s 0 0 eng d
022 _a1097-0215
024 7 _a10.1002/ijc.29686
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMathios, Dimitrios
245 0 0 _aTherapeutic administration of IL-15 superagonist complex ALT-803 leads to long-term survival and durable antitumor immune response in a murine glioblastoma model.
_h[electronic resource]
260 _bInternational journal of cancer
_cJan 2016
300 _a187-94 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntibodies, Monoclonal
_xpharmacology
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aCell Line, Tumor
650 0 4 _aCentral Nervous System Neoplasms
_ximmunology
650 0 4 _aDisease Models, Animal
650 0 4 _aFemale
650 0 4 _aGlioblastoma
_ximmunology
650 0 4 _aHumans
650 0 4 _aImmunologic Memory
650 0 4 _aImmunotherapy
650 0 4 _aInterleukin-15
_xagonists
650 0 4 _aLymphocytes, Tumor-Infiltrating
_ximmunology
650 0 4 _aMice
650 0 4 _aProgrammed Cell Death 1 Receptor
_xantagonists & inhibitors
650 0 4 _aProteins
_xpharmacology
650 0 4 _aRadiosurgery
650 0 4 _aRecombinant Fusion Proteins
650 0 4 _aT-Lymphocyte Subsets
_xdrug effects
650 0 4 _aXenograft Model Antitumor Assays
700 1 _aPark, Chul-Kee
700 1 _aMarcus, Warren D
700 1 _aAlter, Sarah
700 1 _aRhode, Peter R
700 1 _aJeng, Emily K
700 1 _aWong, Hing C
700 1 _aPardoll, Drew M
700 1 _aLim, Michael
773 0 _tInternational journal of cancer
_gvol. 138
_gno. 1
_gp. 187-94
856 4 0 _uhttps://doi.org/10.1002/ijc.29686
_zAvailable from publisher's website
999 _c25074463
_d25074463